How to Apply for Grants

At this time, the Request for Proposals is open for 2021.

Who can apply: 

  • A PI in a research institution who can work with your institutional foundation to accept a grant from a non-profit, and obtain an IRB for your work if needed.
  • We can only support research in the US at this time. (If you are outside the US perhaps you could collaborate with someone in the US)
  • If you are already covered under last year’s grant, please wait till the next year so that we can support more researchers. 
  • If you are new to research benefiting individuals with autism, we welcome your proposals!


  • Please use the templates attached to submit your application back to me by email
  • Deadline: Jan 31, 2021
  • Our Scientific Advisors will review the proposals and you will hear from us in February.

Indirect Costs:
Institutional overheads are not supported by the Brain Foundation and cannot be included in the budget.


Our primary focus is fostering basic and interdisciplinary translational research that leads to the development of effective therapeutics to mitigate the core disabilities in autism. This includes research leading to breakthroughs in understanding and characterization of pathophysiology of autism, basic research, discovery of biomarkers and therapeutic targets for one or more core symptoms, drug repurposing and development of novel drug compounds, devices, and other related areas.

We believe that the most effective use of our funds is to target high need and high impact yet underserved areas of focus within the landscape of investments in research.

Proposals are solicited in these broad areas. (Other related areas that will catalyze research in new directions and lead to novel therapeutics are welcome as well):

  • Basic Science: animal models, tissue cultures, organoids, and others
  • Translational research/human studies leading to new therapeutics, FDA approval of repurposed drugs or new protocols in clinical care.
  • Biomarkers that will help measure treatment response in one or more core symptoms
  • Translational clinical trials that will catalyze a therapeutic towards FDA approval (possible academic/industry collaboration)

Specific areas of focus include: 

  • Innate Immunology: testing and characterization
  • Neurology, specifically epilepsy, novel EEG/MEG studies 
  • Mitochondrial testing and treatment
  • GI basic science and treatment, including IBD and microbiome studies
  • Any promising new areas that have remained unfunded

Subgroups that are priority areas are: 

  • Studies targeting discovery and characterization of rare disease subgroups within the ASD population, with and without genetic characterization
  • Adults with ASD (>18 years of age)
  • Non-speaking children and adolescents (> 8 yrs of age) with dyspraxia and ASD  (basic research to characterize unique medical differences in this group, computational methods and systems biology modalities to analyze unique characteristics, therapeutic targets and treatments for improved motor and/or speech outcomes)
  • Regressive autism

Please contact us at to obtain the Proposal / Application template